Literature DB >> 21411777

XCR1 expression and biased VH gene usage are distinct features of diffuse large B-cell lymphoma initially manifesting in the bone marrow.

Yoriko Yamashita1, Dai Kajiura, Lee Tang, Yuichi Hasegawa, Tomohiro Kinoshita, Shigeo Nakamura, Shinya Akatsuka, Shinya Toyokuni, Naoyoshi Mori.   

Abstract

A total of 29 cases of diffuse large B-cell lymphoma initially manifesting in the bone marrow (BM-DLBCL) were analyzed for V(H) gene sequence, and expression microarray of chemokines and chemokine receptors and immunohistochemical analysis were done. Seminested polymerase chain reaction (PCR) and sequencing analyses of 18 cases revealed that the V(H) gene usage in 6 cases was restricted to V(H)3-7, in 3 cases to V(H)4-34, and in 2 cases to V(H)4-39, which were all previously reported to be autoreactive. In total, 14 of 18 V(H) genes were those associated with autoimmune diseases, including V(H)3-21, V(H)3-23, and V(H)3-48. Furthermore, cDNA microarray analysis specific for chemokine and chemokine receptors revealed that chemokine receptor XCR1 expression was significantly elevated in the BM-DLBCL cases (P < .05), which was confirmed by quantitative reverse transcriptase-PCR and immunohistochemical analysis. Expression of the chemokine receptor XCR1 and frequent usage of autoreactive V(H) genes seem to be distinct characteristics of BM-DLBCL.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21411777     DOI: 10.1309/AJCPCTDC5PY3LXBP

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  8 in total

Review 1.  The role of G protein-coupled receptors in lymphoid malignancies.

Authors:  Adrienne Nugent; Richard L Proia
Journal:  Cell Signal       Date:  2017-08-09       Impact factor: 4.315

2.  Bone Marrow-Liver-Spleen Type of Large B-Cell Lymphoma Associated with Hemophagocytic Syndrome: A Rare Aggressive Extranodal Lymphoma.

Authors:  Kirill A Lyapichev; Jennifer R Chapman; Oleksii Iakymenko; Offiong F Ikpatt; Uygar Teomete; Sandra Patricia Sanchez; Francisco Vega
Journal:  Case Rep Hematol       Date:  2017-08-01

3.  The role of the chemokine receptor XCR1 in breast cancer cells.

Authors:  Xiao Li Yang; Li Guo Qi; Feng Juan Lin; Zhou Luo Ou
Journal:  Breast Cancer (Dove Med Press)       Date:  2017-03-29

4.  Expression of P-REX2a is associated with poor prognosis in endometrial malignancies.

Authors:  Sho Takeshita; Yoriko Yamashita; Kosuke Shiomi; Nako Suzuki; Jun Yoshida; Aya Naiki-Ito; Shugo Suzuki; Shinya Akatsuka; Shinya Toyokuni; Takashi Takahashi; Shoko Mase; Atsushi Arakawa; Mayumi Sugiura-Ogasawara; Satoru Takahashi
Journal:  Oncotarget       Date:  2018-05-15

5.  Fifteen mRNA-lncRNA expression-based signature predicted the survival of late-staged head and neck squamous cell carcinoma.

Authors:  He Ren; Huaping Li; Ping Li; Yuhui Xu; Gang Liu; Liping Sun
Journal:  Biosci Rep       Date:  2020-07-31       Impact factor: 3.840

6.  Met is the most frequently amplified gene in endometriosis-associated ovarian clear cell adenocarcinoma and correlates with worsened prognosis.

Authors:  Yoriko Yamashita; Shinya Akatsuka; Kanako Shinjo; Yasushi Yatabe; Hiroharu Kobayashi; Hiroshi Seko; Hiroaki Kajiyama; Fumitaka Kikkawa; Takashi Takahashi; Shinya Toyokuni
Journal:  PLoS One       Date:  2013-03-04       Impact factor: 3.240

7.  The immunosignature of canine lymphoma: characterization and diagnostic application.

Authors:  Stephen Albert Johnston; Douglas H Thamm; Joseph Barten Legutki
Journal:  BMC Cancer       Date:  2014-09-08       Impact factor: 4.430

8.  Immunoglobulin gene repertoire diversification and selection in the stomach - from gastritis to gastric lymphomas.

Authors:  Miri Michaeli; Hilla Tabibian-Keissar; Ginette Schiby; Gitit Shahaf; Yishai Pickman; Lena Hazanov; Kinneret Rosenblatt; Deborah K Dunn-Walters; Iris Barshack; Ramit Mehr
Journal:  Front Immunol       Date:  2014-06-03       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.